Physician profile
Krupal Jay Hari
NPI 1003347881
$1,056.47
in general payments reported to CMS, 2019-2025
16 companies · $499 in 2025
The $499 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $21.27 · 2023: $102 · 2024: $435 · 2025: $499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,035.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $288.83 | 2024-2025 | Lifevest |
| Amgen INC. | $138.43 | 2023-2025 | Repatha, Repatha |
| Pfizer INC. | $135.11 | 2023-2025 | |
| Boston Scientific Corporation | $79.24 | 2024-2025 | Bodyguardian, Watchman Flx |
| Esperion Therapeutics, INC. | $72.83 | 2024-2025 | Nexletol |
| Edwards Lifesciences Corporation | $67.35 | 2024-2025 | Sapien 3 Ultra Resilia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.61 | 2024 | Jardiance |
| Janssen Pharmaceuticals, INC | $41.73 | 2024 | Xarelto |
| Abbott Laboratories | $40.46 | 2022-2025 | Aveir |
| Bayer Healthcare Pharmaceuticals INC. | $38.26 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $23.70 | 2024 | Arcalyst |
| Heartflow, INC. | $20.90 | 2023 | Ffrct |
| Novo Nordisk INC | $15.59 | 2024 | Wegovy |
| Novartis Pharmaceuticals Corporation | $14.72 | 2023 | |
| Cvrx, INC. | $14.71 | 2023 | Barostim Neo System |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $14.00 | 2024 | Wainua |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krupal Hari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.